These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19879300)

  • 1. An enzymatic virus-like particle assay for sensitive detection of virus entry.
    Tscherne DM; Manicassamy B; García-Sastre A
    J Virol Methods; 2010 Feb; 163(2):336-43. PubMed ID: 19879300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzymatic assay for detection of viral entry.
    Tscherne DM; García-Sastre A
    Curr Protoc Cell Biol; 2011 Jun; Chapter 26():Unit 26.12. PubMed ID: 21688257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics.
    Wolf MC; Wang Y; Freiberg AN; Aguilar HC; Holbrook MR; Lee B
    Virol J; 2009 Jul; 6():119. PubMed ID: 19646266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
    Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
    Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and application of an infectious virus-like particle system for Marburg virus.
    Wenigenrath J; Kolesnikova L; Hoenen T; Mittler E; Becker S
    J Gen Virol; 2010 May; 91(Pt 5):1325-34. PubMed ID: 20071483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
    Xiao JH; Rijal P; Schimanski L; Tharkeshwar AK; Wright E; Annaert W; Townsend A
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
    Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
    Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
    Chen BJ; Leser GP; Morita E; Lamb RA
    J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay.
    Gavrilov V; Orekov T; Alabanza C; Porika U; Jiang H; Connolly K; Pincus S
    J Virol Methods; 2011 May; 173(2):364-73. PubMed ID: 21419169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
    Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
    Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
    J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.
    Weiwei G; Xuexing Z; Chong W; Yongkun Z; Qi W; Hualei W; Gary W; Ying X; Haijun W; Zengguo C; Na F; Hang C; Tiecheng W; Yuwei G; Junjie S; Songtao Y; Xianzhu X
    J Med Virol; 2017 Dec; 89(12):2069-2074. PubMed ID: 28402024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a quantitation assay for fluorescently tagged HIV-1 virus-like particles.
    Gutiérrez-Granados S; Cervera L; Gòdia F; Carrillo J; Segura MM
    J Virol Methods; 2013 Oct; 193(1):85-95. PubMed ID: 23707924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
    Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
    Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.